← Back to Search

Managing Infectious Vulvovaginitis for Precancerous Conditions of the Vulva

N/A
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Is scheduled or planning for WLE/SPV
Must be 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial measures the rate of vulvovaginitis in patients who need a vulvar surgery and how it relates to wound healing and infection. A swab will be taken before surgery, and the outcome will be checked by phone and physical exam.

Who is the study for?
This trial is for adults with non-cancerous vulvar conditions needing surgery in central VA. Participants must not be pregnant, recently on antibiotics, have a history of cancer treatments within 3 years, or have immune system issues. They should be able to consent and not have uncontrolled diabetes or severe infections.Check my eligibility
What is being tested?
The study aims to measure the rate of infectious vulvovaginitis and its correlation with wound complications after surgical excision for premalignant lesions. Patients will be swabbed preoperatively to test for common causes like BV, trichomonas, and candida.See study design
What are the potential side effects?
There are no direct side effects from the interventions being studied since it involves diagnostic testing rather than treatment administration. However, potential risks may include discomfort from swabbing and standard surgical risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a lumpectomy or partial mastectomy.
Select...
I am 18 years old or older.
Select...
My vulvar condition is confirmed not to be cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
rate of vulvovaginitis with rate of wound cellulitis and incisional breakdown
the rate of perioperative vulvovaginitis

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
754 Previous Clinical Trials
1,244,982 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently accepting participants?

"Clinicaltrials.gov reports that the trial first posted on November 14th 2023 is not taking any new patients at this time, although there are 41 other ongoing studies recruiting participants presently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
Alice Chen 2023. "Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06070454.
~61 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top